Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Drops By 34.6%

Edap Tms S.A. (NASDAQ:EDAP) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 26,300 shares, a drop of 34.6% from the February 28th total of 40,200 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average daily trading volume, of 75,200 shares, the short-interest ratio is currently 0.3 days.

Analyst Ratings Changes

EDAP has been the subject of several research reports. StockNews.com began coverage on Edap Tms in a research report on Friday. They issued a “hold” rating for the company. HC Wainwright reiterated a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a research note on Friday. Finally, Piper Sandler reduced their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday.

Institutional Trading of Edap Tms

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Parkman Healthcare Partners LLC acquired a new stake in shares of Edap Tms during the third quarter worth about $395,000. Jane Street Group LLC raised its position in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the last quarter. Schonfeld Strategic Advisors LLC raised its position in Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares during the last quarter. Millennium Management LLC boosted its stake in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares during the period. Finally, BNP Paribas Financial Markets increased its stake in Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 25,650 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Stock Down 3.2 %

Shares of Edap Tms stock traded down $0.07 during trading on Friday, hitting $2.15. 143,513 shares of the stock were exchanged, compared to its average volume of 86,608. The stock has a market cap of $79.77 million, a price-to-earnings ratio of -3.31 and a beta of 0.37. The firm’s 50-day moving average price is $2.42 and its 200 day moving average price is $2.51. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 12-month low of $1.96 and a 12-month high of $8.50.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. As a group, analysts forecast that Edap Tms will post -0.6 earnings per share for the current fiscal year.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.